MARKET

PLYGF

PLYGF

PolyPeptide Group
OTCPK
43.00
NaN%
Opening 09:30 08/19 EDT
OPEN
--
PREV CLOSE
43.00
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
50.00
52 WEEK LOW
31.50
MARKET CAP
1.42B
P/E (TTM)
-57.3257
1D
5D
1M
3M
1Y
5Y
1D
PolyPeptide downgraded to Hold from Buy at Berenberg
TipRanks · 1d ago
Barclays downgrades PolyPeptide Group AG (PPGN) to a Hold
TipRanks · 5d ago
PolyPeptide lifts 2026 outlook after strong H1 surge in peptide demand
TipRanks · 6d ago
Samsung Biologics Moves to Acquire Fast‑Growing Peptide CDMO PolyPeptide
TipRanks · 07/20 00:32
PolyPeptide downgraded to Sector Perform from Outperform at RBC Capital
TipRanks · 07/07 12:05
RBC Capital Sticks to Its Hold Rating for PolyPeptide Group AG (PPGN)
TipRanks · 07/07 06:15
PolyPeptide Group AG (PPGN) Gets a Buy from RBC Capital
TipRanks · 06/23 06:55
PolyPeptide price target raised to CHF 38 from CHF 35 at Berenberg
TipRanks · 06/16 16:17
More
About PLYGF
Polypeptide Group AG is a Switzerland-based Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development as well as in generic products.

Webull offers Polypeptide Group AG stock information, including OTCPK: PLYGF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PLYGF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PLYGF stock methods without spending real money on the virtual paper trading platform.